Evidence map›Paper›PMID 36966429›Full record

ArticleArchives of gynecology and obstetrics2024

Fetal NT-proBNP levels and their course in severe anemia during intrauterine treatment.

Pauline Siebers, Ulrich Gembruch, Waltraut Maria Merz, Florian Recker, Andreas Müller, Brigitte Strizek, Annegret Geipel, Christoph Berg, Eva Christin Weber

Open access · hybridAbstract read
In one paragraph

Article in Archives of gynecology and obstetrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Prenatal parvovirus B19 infection.Archives of gynecology and obstetrics · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Pauline SiebersDepartment of Obstetrics and Prenatal Medicine, University Hospital Bonn, Bonn, Germany.
Ulrich GembruchDepartment of Obstetrics and Prenatal Medicine, University Hospital Bonn, Bonn, Germany.
Waltraut Maria MerzDepartment of Obstetrics and Prenatal Medicine, University Hospital Bonn, Bonn, Germany.
Florian ReckerDepartment of Obstetrics and Prenatal Medicine, University Hospital Bonn, Bonn, Germany.
Andreas MüllerDepartment of Neonatology and Pediatric Intensive Care, University Hospital Bonn, Bonn, Germany.
Brigitte StrizekDepartment of Obstetrics and Prenatal Medicine, University Hospital Bonn, Bonn, Germany.
Annegret GeipelDepartment of Obstetrics and Prenatal Medicine, University Hospital Bonn, Bonn, Germany.
Christoph BergDepartment of Obstetrics and Prenatal Medicine, University Hospital Bonn, Bonn, Germany.
Eva Christin WeberDepartment of Obstetrics and Prenatal Medicine, University Hospital Bonn, Bonn, Germany. eva.weber@uk-koeln.de.ORCID 0000-0002-6633-8464
University Hospital Bonn · DEUniversity of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIn adults and fetuses, N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a marker of cardiac failure and myocardial remodelling. We examined the effect of anemia and intrauterine transfusion (IUT) on NT-proBNP concentrations in fetuses with anemia and established gestational age-dependent reference values of a control group.

methodsWe analyzed NT-proBNP levels in anemic fetuses that underwent serial intrauterine transfusions (IUT), focusing on different causes and severity of anemia and comparing the results to a non-anemic control group.

resultsIn the control group, the average NT-proBNP concentration was 1339 ± 639 pg/ml, decreasing significantly with increasing gestational age (R = - 74.04, T = - 3.65, p = 0.001). Subjects had significantly higher NT-proBNP concentrations before initiation of IUT therapy (p < 0.001), showing fetuses with parvovirus B19 (PVB19) infection having the highest concentrations. Hydropic fetuses also showed an increased NT-proBNP concentration compared to non-hydropic fetuses (p < 0.001). During the course of therapy, NT-proBNP concentration before subsequent IUT decreased significantly from pathologically high levels, while MoM-Hb and MoM-MCA-PSV remained pathological.

conclusionNT-pro BNP levels in non-anemic fetuses are higher than in postnatal life, decreasing with ongoing pregnancy. Anemia is a hyperdynamic state and its severity correlates with circulating NT-proBNP levels. Highest concentrations occur in fetuses with hydrops and with PVB19 infection, respectively. Treatment by IUT leads to a normalisation of NT-proBNP concentrations, so the measurement of its levels may be useful in therapy monitoring.

Indexed as

AnemiaFetal DiseasesPeptide FragmentsAdultBlood Transfusion, IntrauterineFemaleFetusHumansNatriuretic Peptide, BrainPregnancyNatriuretic Peptide, BrainPeptide Fragmentspro-brain natriuretic peptide (1-76)Cardiac failureFetal anemiaFetal heartHydrops fetalisIntrauterine transfusionNT-proBNP

Identifiers

PMID36966429
PMCPMC10894143
OpenAlexW4360965479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.